N 6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy

Area of Science:

• Biochemistry
• Immunology
• Endocrinology

Background:

• Diabetic vasculopathy, including retinopathy, is a major cause of illness.
• Inflammation is key in diabetic complication development.
• Macrophage polarization influences diabetic microvasculopathy.

Purpose of the Study:

• Investigate the role of N6-methyladenosine (m6A) modification and FTO in macrophage polarization.
• Determine FTO's impact on diabetic microvasculopathy.
• Elucidate the molecular mechanisms involved.

Main Methods:

• In vitro studies on macrophage polarization and endothelial cell interaction.
• In vivo experiments in diabetic mouse models.
• Analysis of m6A modification levels and FTO protein expression.
• Investigation of the PI3K/AKT signaling pathway.

Main Results:

• Diabetes promotes M1 proinflammatory macrophage polarization, reducing m6A levels.
• FTO regulates m6A modification and macrophage polarization under diabetic conditions.
• FTO deficiency exacerbates retinal inflammation and microvascular dysfunction in diabetic mice.
• FTO stabilizes mRNA via m6A-YTHDF2, activating PI3K/AKT signaling.

Conclusions:

• FTO plays a critical role in regulating macrophage polarization and inflammation in diabetic vasculopathy.
• FTO acts through an m6A-dependent pathway to influence vascular complications.
• Targeting FTO presents a potential therapeutic strategy for diabetic vascular diseases.